Sofinnova Biovelocita II is a Paris-based venture capital fund managed by Sofinnova Partners. €165m reported at final close (source published March 2025).
Biotech accelerator creating and backing European biotechs
Amounts come from the linked public source. A first close is not the final fund size, and a reported close does not confirm that the fund is investing now. Headquarters describe where the manager is based, not where it invests.